Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Neurons need a continuous supply of glucose, the major source of energy for mammalian brain metabolism. The central nervous system is protected by three main physiological cell barriers. Cell membranes are impermeable for glucose, therefore glucose is transferred across the cell membranes by specific transport proteins: sodium-independent glucose transporters (GLUTs), encoded by SLC2 genes, and sodium-dependent glucose transporters (for example SGLTs), encoded by SLC5 genes. Human brain expresses 10 GLUT proteins and 10 proteins encoded by SLC5 genes. In patients with brain diseases, particularly Alzheimer's (AD) and Huntington's diseases, abnormalities in neuronal glucose metabolism have been showed. The levels of GLUT1 and GLUT3, the major brain glucose transporters, are decreased, especially in the cerebral cortex. Therefore, in AD, hypometabolism of glucose and deficits in energy are observed. Production of ATP from glucose metabolism in sporadic AD declines to 50% and the tendency to decline continues throughout the progression of the disease. This decrease is correlated with O-GlcAcetylation and tau hyperphosphorylation, as the compensatory mechanisms in AD are the utilization of endogenous brain substances and drastic increase in GLUT2 levels. The present review focuses on the changes in the expression of glucose transporters due to AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“researchers asserted that besides its role in glucose reabsorption, SGLT may exhibit other distinct functions in CNS.13–15”
From Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice (2020) · cites this paper as [13]
Citations
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 2×
“Therefore, the concept of AD was proposed as “type 3 diabetes” [124].”
The SLC2 (GLUT) family of membrane transporters
Mueckler, M., & Thorens, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.001 · Cited by 1,328
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166 · cited 1×
“A (cid:2) 40 and A (cid:2) 42 are generated by the proteolytic cleavage of A (cid:2) PP with (cid:2) - and (cid:4) -secretases [132].”
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Insulin receptors are widely distributed in the central nervous system of the rat
HAVRANKOVA, J., ROTH, J., & BROWNSTEIN, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,111
De Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800
Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging
Magistretti, P. J., & Pellerin, L. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0471 · Cited by 749 · cited 1×
“On the other hand, Magistretti and Pellerin [4] and Larrabe [5] suggest lactate, produced by astrocytes, as another source of energy utilized by neuronal cells [4, 5].”
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709
McClean, P. L., Parthsarathy, V., Faivre, E., & Hölscher, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-11.2011 · Cited by 698
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Role for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 637
The dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616 · cited 1×
“Keaney and Campbell [144] wrote “It is still unclear whether reduced GLUT-1 levels in AD represents lower energy demands in a degenerating brain or whether the primary insult at the BBB and precedes brain atrophy”.”
Brain fuel metabolism, aging, and Alzheimer’s disease
Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., et al. (2011) · Nutrition · doi:10.1016/j.nut.2010.07.021 · Cited by 614
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · cited 2×
“If these assumptions are right, the step to prevent and treat AD will be providing more source of energy to the brain [143].”
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522 · cited 2×
“Insulin stimulation reduces tau protein phosphorylation and promotes its binding to microtubules [128] and regulates soluble A (cid:2) PP release [140].”
Glucose transporter proteins in brain
Maher, F., Vannucci, S. J., & Simpson, I. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926364 · Cited by 511 · cited 1×
“Highly glycosylated isoform of GLUT1, 55 kDa, is expressed in microvessels (endothelial cells) [62], whereas, a less glycosylated isoform, 45 kDa, is localized in glia (astrocytes and oligodendrocytes) [65, 66].”
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
Liu, Y., Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2011) · The Journal of Pathology · doi:10.1002/path.2912 · Cited by 502
Blázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 491
Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490
The source of cerebral insulin
Banks, W. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.040 · Cited by 489 · cited 1×
“Insulin can cross the BBB using insulin transporter-mediated active transport [118, 119].”
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
The facilitative glucose transporter GLUT3: 20 years of distinction
Simpson, I. A., Dwyer, D., Malide, D., Moley, K. H., Travis, A., & Vannucci, S. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90388.2008 · Cited by 473 · cited 1×
“ThetransportersGLUT1andGLUT3playamajor roleintheglucoseuptakeofthebrain[24,25].”
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439 · cited 2×
“Liu et al. [12] suggest that decreased expression of GLUTs in BBB causes brain hypometabolism in AD-affected brain, and the impaired brain glucose metabolism contributes to the pathologies observed in AD-affected brain [36].”
Coucke, P. J., Willaert, A., Wessels, M. W., Callewaert, B., Zoppi, N., De Backer, J., Fox, J. E., Mancini, G. M. S., Kambouris, M., Gardella, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1764 · Cited by 399
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J.-Z., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 398 · cited 1×
“Tau protein is recognized to play roles in promoting microtubule assembly and stabilizing the microtubules [126].”
Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.035 · Cited by 394 · cited 9×
“The decrease in GLUT1 and GLUT3 levels were correlated with O-GlcNAcylation and tau hyper-phosphorylation [12].”
InfluentialInsulin resistance and Alzheimer's disease
De La Monte, S. M. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.475 · Cited by 392
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Kickstein, E., Krauss, S., Thornhill, P., Rutschow, D., Zeller, R., Sharkey, J., Williamson, R., Fuchs, M., Köhler, A., Glossmann, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912793107 · Cited by 380 · cited 1×
“The biguanide metformin improves fasting insulin levels and can also cross the BBB [154].”
Hsu, C.-C., Wahlqvist, M. L., Lee, M.-S., & Tsai, H.-N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101524 · Cited by 372 · cited 1×
“It was observed that the treatment of patients with diabetes with metformin reduces incidence of dementia [155].”
Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369
Weber, Y. G., Storch, A., Wuttke, T. V., Brockmann, K., Kempfle, J., Maljevic, S., Margari, L., Kamm, C., Schneider, S. A., Huber, S. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34438 · Cited by 363
Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease
Kalaria, R. N., & Harik, S. I. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07399.x · Cited by 338
Glucose transporter expression in the central nervous system: relationship to synaptic function
McEwen, B. S., & Reagan, L. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.041 · Cited by 331 · cited 4×
“The GLUT3, like GLUT1, is the predominant GLUT protein responsible for glucose transport in brain [24].”
InfluentialZhao, L., Teter, B., Morihara, T., Lim, G. P., Ambegaokar, S. S., Ubeda, O. J., Frautschy, S. A., & Cole, G. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2860-04.2004 · Cited by 329
The insulin signalling pathway
Lizcano, J. M., & Alessi, D. R. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00777-7 · Cited by 325
HOUTEN, M. V., POSNER, B. I., KOPRIWA, B. M., & BRAWER, J. R. (1979) · Endocrinology · doi:10.1210/endo-105-3-666 · Cited by 321
Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
Chen, J., Williams, S., Ho, S., Loraine, H., Hagan, D., Whaley, J. M., & Feder, J. N. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0006-4 · Cited by 307
Glucose transport families SLC5 and SLC50
Wright, E. M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.002 · Cited by 301 · cited 3×
“In humans, this transporter is detected mainly in cholinergic neurons of the submucosal and myenteric plexus and at the neuromuscular junction [59], where plasma glucose variations modulate the membrane potential of neurons.”
InfluentialDistribution of insulin receptor-like immunoreactivity in the rat forebrain
Unger, J., McNeill, T. H., Moxley, R. T., White, M., Moss, A., & Livingston, J. N. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90036-5 · Cited by 294 · cited 1×
“The highest concentration of insulin receptors was observed in neuronal cell bodies of the hippocampus, olfactory bulb, hypothalamus, and cerebral cortex [116, 117].”
The role of glucose transporters in brain disease: Diabetes and Alzheimer’s disease
Shah, K., DeSilva, S., & Abbruscato, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012629 · Cited by 288 · cited 7×
“These results were confirmed in animal studies [17].”
InfluentialGLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters
Deng, D., & Yan, N. (2016) · Protein Science · doi:10.1002/pro.2858 · Cited by 275 · cited 1×
“These proteins facilitate the diffusion of substrates across cellular membranes along a concentration gradient [61].”
Alafuzoff, I., Iqbal, K., Friden, H., Adolfsson, R., & Winblad, B. (1987) · Acta Neuropathologica · doi:10.1007/bf00688184 · Cited by 266
Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain
Magistretti, P. J., & Pellerin, L. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.5.177 · Cited by 261
Dick, A. P., Harik, S. I., Klip, A., & Walker, D. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7233 · Cited by 247
Facilitated Hexose Transporters: New Perspectives on Form and Function
Manolescu, A. R., Witkowska, K., Kinnaird, A., Cessford, T., & Cheeseman, C. (2007) · Physiology · doi:10.1152/physiol.00011.2007 · Cited by 235
Vandal, M., White, P. J., Tremblay, C., St-Amour, I., Chevrier, G., Emond, V., Lefrançois, D., Virgili, J., Planel, E., Giguere, Y., et al. (2014) · Diabetes · doi:10.2337/db14-0375 · Cited by 233
Tekkök, S. B., Brown, A. M., Westenbroek, R., Pellerin, L., & Ransom, B. R. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20573 · Cited by 224
Developmental Expression of GLUT1 and GLUT3 Glucose Transporters in Rat Brain
Vannucci, S. J. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010240.x · Cited by 223
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219 · cited 1×
“In post-mortem studies in human AD-affected brains, the activation of MAPK occurs at a very early stage [138].”
Is there an astrocyte–neuron ketone body shuttle?
Guzmán, M., & Blázquez, C. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00370-2 · Cited by 208
The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update
Hoyer, S. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200028 · Cited by 205
The rat blood-brain barrier transcriptome
Enerson, B. E., & Drewes, L. R. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600249 · Cited by 205 · cited 1×
“The SGLT2 mRNA was shown to be present in isolated rat brain microvessels [110].”
García, M. D. L. A., Millán, C., Balmaceda‐Aguilera, C., Castro, T., Pastor, P., Montecinos, H., Reinicke, K., Zúñiga, F., Vera, J. C., Oñate, S. A., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01892.x · Cited by 201
Glucose transporter 2 (GLUT 2): expression in specific brain nuclei
Leloup, C., Arluison, M., Lepetit, N., Cartier, N., Marfaing-Jallat, P., Ferré, P., & Pénicaud, L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90653-x · Cited by 195
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195
GLUT4 glucose transporter expression in rodent brain: effect of diabetes
Vannucci, S. J., Koehler-Stec, E. M., Li, K., Reynolds, T. H., Clark, R., & Simpson, I. A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00103-6 · Cited by 193
Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies
Jagust, W. J., Seab, J. P., Huesman, R. H., Valk, P. E., Mathis, C. A., Reed, B. R., Coxson, P. G., & Budinger, T. F. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.65 · Cited by 187 · cited 1×
“It was found that glucose transport in the human AD-affected brain is reduced in the most metabolically-active brain regions such as cortex, hippocampus, and cerebral microvessels [30–32].”
Immunohistochemical localization and quantification of glucose transporters in the mouse brain
Choeiri, C., Staines, W., & Messier, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00619-4 · Cited by 179
Exercise-Induced Changes in Local Cerebral Glucose Utilization in the Rat
Vissing, J., Andersen, M., & Diemer, N. H. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199607000-00025 · Cited by 171
El Messari, S., Leloup, C., Quignon, M., Brisorgueil, M.-J., Penicaud, L., & Arluison, M. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981005)399:4<492::aid-cne4>3.0.co;2-x · Cited by 168
Identification of a Novel Na+/myo-Inositol Cotransporter
Coady, M. J., Wallendorff, B., Gagnon, D. G., & Lapointe, J.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204321200 · Cited by 167
Insulin resistance and pathological brain ageing
Cholerton, B., Baker, L. D., & Craft, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03464.x · Cited by 160
Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure
Zhong, N., & Weisgraber, K. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800009200 · Cited by 159 · cited 1×
“Therefore, the therapeutics for type 2 diabetes should also be effective for AD [149].”
Oxidative energy metabolism in Alzheimer brain: Studies in early-onset and late-onset cases
Hoyer, S. (1992) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159971 · Cited by 159
Arluison, M., Quignon, M., Nguyen, P., Thorens, B., Leloup, C., & Pénicaud, L. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.05.009 · Cited by 158 · cited 1×
“According to their observations, GLUT2 was found especially in limbic areas and related nuclei [76].”
Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3
Uemura, E., & Greenlee, H. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.035 · Cited by 149
Piert, M., Koeppe, R. A., Giordani, B., Berent, S., & KUHL, D. E. (1996) · PubMed · Cited by 148
Hoyer, S., & Nitsch, R. M. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258634 · Cited by 146 · cited 1×
“As the first of compensatory mechanisms in AD, the utilization of endogenous substances, such as glutamate and fatty acids occurs [48, 49].”
Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease
Hunt, A., Schönknecht, P., Henze, M., Seidl, U., Haberkorn, U., & Schröder, J. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.12.003 · Cited by 146 · cited 1×
“PET imaging studies showed that altered glucose transport occurs early in AD [145].”
Corticosterone Impairs Insulin-Stimulated Translocation of GLUT4 in the Rat Hippocampus
Piroli, G. G., Grillo, C. A., Reznikov, L. R., Adams, S., McEwen, B. S., Charron, M. J., & Reagan, L. P. (2007) · Neuroendocrinology · doi:10.1159/000101694 · Cited by 146 · cited 1×
“It is insulin-sensitive, and insulin increases its expression and translocation in brain [83].”
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy
Mullen, S. A., Marini, C., Suls, A., Mei, D., Della Giustina, E., Buti, D., Arsov, T., Damiano, J., Lawrence, K., De Jonghe, P., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.102 · Cited by 138
Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01223-7 · Cited by 137
Expression of the Na+‐d‐Glucose Cotransporter SGLT1 in Neurons
Poppe, R., Karbach, U., Gambaryan, S., Wiesinger, H., Lutzenburg, M., Kraemer, M., Witte, O. W., & Koepsell, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010084.x · Cited by 134
Discrete brain areas express the insulin-responsive glucose transporter GLUT4
Leloup, C., Arluison, M., Kassis, N., Lepetit, N., Cartier, N., Ferré, P., & Pénicaud, L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00306-d · Cited by 131
Hooijmans, C. R., Graven, C., Dederen, P. J. W. C., Tanila, H., van Groen, T., & Kiliaan, A. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.063 · Cited by 130
Lactate Metabolism and Its Effects on Glucose Metabolism in an Excised Neural Tissue
Larrabee, M. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041734.x · Cited by 129
Relation of potassium transport to oxidative metabolism in isolated brain capillaries
Goldstein, G. W. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012613 · Cited by 129 · cited 1×
“As found by Goldstein [8] and Guzman and Blazquez [9], ketones can also be a source of energy for brain; ketone bodies can be utilized by brain capillaries and astrocytes.”
Glucose transporter glut 5 expression in microglial cells
Payne, J., Maher, F., Simpson, I., Mattice, L., & Davies, P. (1997) · Glia · doi:10.1002/(sici)1098-1136(199711)21:3<327::aid-glia7>3.0.co;2-1 · Cited by 126
Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells
Lisinski, I., Schürmann, A., Joost, H., Cushman, S. W., & Al‐Hasani, H. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580517 · Cited by 122
Intranasal Insulin Ameliorates Tau Hyperphosphorylation in a Rat Model of Type 2 Diabetes
Yang, Y., Ma, D., Wang, Y., Jiang, T., Hu, S., Zhang, M., Yu, X., & Gong, C.-X. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121294 · Cited by 120
Salkovic-Petrisic, M., Osmanovic, J., Grünblatt, E., Riederer, P., & Hoyer, S. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1184 · Cited by 119
Vemula, S., Roder, K. E., Yang, T., Bhat, G. J., Thekkumkara, T. J., & Abbruscato, T. J. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146589 · Cited by 119
Regional cerebral glucose transport and utilization in Alzheimer's disease
Friedland, R. P., Jagust, W. J., Huesman, R. H., Koss, E., Knittel, B., Mathis, C. A., Ober, B. A., Mazoyer, B. M., & Budinger, T. F. (1989) · Neurology · doi:10.1212/wnl.39.11.1427 · Cited by 116 · cited 1×
“It was found that glucose transport in the human AD-affected brain is reduced in the most metabolically-active brain regions such as cortex, hippocampus, and cerebral microvessels [30–32].”
Glucose transport to the brain: A systems model
Qutub, A. A., & Hunt, C. A. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.002 · Cited by 113
Farrell, C. L., Yang, J., & Pardridge, W. M. (1992) · Journal of Histochemistry & Cytochemistry · doi:10.1177/40.2.1552163 · Cited by 111
Nagamatsu, S., Sawa, H., Kamada, K., Nakamichi, Y., Yoshimoto, K., & Hoshino, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80697-s · Cited by 110
Huang, Y., Lei, L., Liu, D., Jovin, I., Russell, R., Johnson, R. S., Di Lorenzo, A., & Giordano, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209281109 · Cited by 110
Stuart, C. A., Howell, M. E. A., Zhang, Y., & Yin, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0162 · Cited by 109
PEDERSEN, W., & FLYNN, E. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.003 · Cited by 108
Zeller, K., Rahner-Welsch, S., & Kuschinsky, W. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199702000-00010 · Cited by 106
Metabolic/signal transduction hypothesis of Alzheimer?s disease and other tauopathies
Iqbal, K., & Grundke, I. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0951-y · Cited by 102 · cited 1×
“GSK-3 (cid:2) contributes to the hyperphosphorylation of tau protein [125].”
Shepherd, P. R., Gibbs, E. M., Wesslau, C., Gould, G. W., & Kahn, B. B. (1992) · Diabetes · doi:10.2337/diab.41.10.1360 · Cited by 101
Identification of scyllo‐inositol in proton NMR spectra of human brain in vivo
Michaelis, T., Helms, G., Merboldt, K., Hänicke, W., Bruhn, H., & Frahm, J. (1993) · NMR in Biomedicine · doi:10.1002/nbm.1940060116 · Cited by 100
Glut1 deficiency: Inheritance pattern determined by haploinsufficiency
Rotstein, M., Engelstad, K., Yang, H., Wang, D., Levy, B., Chung, W. K., & De Vivo, D. C. (2010) · Annals of Neurology · doi:10.1002/ana.22088 · Cited by 98
Piroli, G. G., Grillo, C. A., Hoskin, E. K., Znamensky, V., Katz, E. B., Milner, T. A., McEwen, B. S., Charron, M. J., & Reagan, L. P. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10368 · Cited by 97
Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain
Kobayashi, M., Nikami, H., Morimatsu, M., & Saito, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12845-7 · Cited by 97 · cited 1×
“Expression of GLUT4 was observed in hypothalamus [84], cerebellum [42, 85], sensomotor cortex [42], hippocampus [86], and pituitary [87].”
Messier, C., Whately, K., Liang, J., Du, L., & Puissant, D. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.12.011 · Cited by 95 · cited 1×
“High fructose diets do not upregulate GLUT5 in the brain [96].”
Ontogeny and cellular distribution of brain glucose transporter gene expression
Bondy, C. A., Lee, W., & Zhou, J. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90027-y · Cited by 94
Brain glucose sensing mechanism and glucose homeostasis
Pénicaud, L., Leloup, C., Lorsignol, A., Alquier, T., & Guillod, E. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200209000-00013 · Cited by 93
Arluison, M., Quignon, M., Thorens, B., Leloup, C., & Pénicaud, L. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.06.002 · Cited by 93
Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice
Sala‐Rabanal, M., Hirayama, B. A., Ghezzi, C., Liu, J., Huang, S., Kepe, V., Koepsell, H., Yu, A., Powell, D. R., Thorens, B., et al. (2016) · The Journal of Physiology · doi:10.1113/jp271904 · Cited by 92
Pearson-Leary, J., & McNay, E. C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112192 · Cited by 91
Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier
Mantych, G. J. (1993) · Endocrinology · doi:10.1210/en.132.1.35 · Cited by 91
Deregulation of brain insulin signaling in Alzheimer’s disease
Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 90
Sankar, R., Thamotharan, S., Shin, D. H., Moley, K. H., & Devaskar, S. U. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00487-4 · Cited by 90
Nualart, F., Godoy, A., & Reinicke, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01078-1 · Cited by 89 · cited 1×
“GLUT5 was identified in different human cells such as microglia [91] and cerebellar Purkinje cells in fetus [92], BBB [93], and in animal brain such as mouse cerebellum [94] and rat hippocampus [95].”
Hoyer, S., & Lannert, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07842.x · Cited by 89
McCall, A. L., Bueren, A. M. V., Moholt-Siebert, M., Cherry, N. J., & Woodward, W. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90896-6 · Cited by 88
Expression, regulation, and functional role of glucose transporters (GLUTs) in brain
Dwyer, D. S., Vannucci, S. J., & Simpson, I. A. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51005-9 · Cited by 87 · cited 1×
“Dwyer et al. [58] suggest that GLUT2 is expressed only in astrocytes, while Manolescu et al. [71] suggest that GLUT2 is probably mainly expressed in astrocytes, and other researchers [72, 73] have found expression of this transporter in tanycytes.”
Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells
Lisinski, I., Schürmann, A., Joost, H., et al. (2001) · Biochemical Journal · doi:10.1042/bj3580517 · Cited by 84
Regulated exocytosis of an H+/myo‐inositol symporter at synapses and growth cones
Uldry, M., Steiner, P., Zurich, M., Béguin, P., Hirling, H., Dolci, W., & Thorens, B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600072 · Cited by 79
Regulation of brain glucose transporters by glucose and oxygen deprivation
Bruckner, B. A., Ammini, C. V., Otal, M. P., Raizada, M. K., & Stacpoole, P. W. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90098-7 · Cited by 79 · cited 1×
“Abnormalities in glucose homeostasis have been showed in pathological environmental conditions for neurons, such as hyper-glycemia and hypoxia [17, 19].”
Kinase activities increase during the development of tauopathy in htau mice
Kelleher, I., Garwood, C., Hanger, D. P., Anderton, B. H., & Noble, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04930.x · Cited by 78 · cited 1×
“Animal studies have showed a positive correlation between activated MAPK and the amount of aggregated tau protein [142].”
Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter
Apparsundaram, S., Ferguson, S. M., & Blakely, R. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290711 · Cited by 78
Ibberson, M. R., Riederer, B. M., Uldry, M., Guhl, B., Roth, J., & Thorens, B. (2002) · Endocrinology · doi:10.1210/en.143.1.276 · Cited by 77
Biessels, G. J., Bravenboer, B., & Gispen, W. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.057 · Cited by 76
Rizvi, S., Shakil, S., Biswas, D., Shakil, S., Shaikh, S., Bagga, P., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660160 · Cited by 71
Yu, S., Zhao, T., Guo, M., Fang, H., Ma, J., Ding, A.-S., Wang, F., Chan, P., & Fan, M. (2008) · Brain Research · doi:10.1016/j.brainres.2005.04.029 · Cited by 68
Impaired Neuronal Insulin Signaling Precedes Aβ42 Accumulation in Female AβPPsw/PS1ΔE9 Mice
Chua, L.-M., Lim, M.-L., Chong, P.-R., Hu, Z. P., Cheung, N. S., & Wong, B.-S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111880 · Cited by 66
Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia
Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02017-9 · Cited by 66 · cited 1×
“As the first of compensatory mechanisms in AD, the utilization of endogenous substances, such as glutamate and fatty acids occurs [48, 49].”
Expression of fructose sensitive glucose transporter in the brains of fructose-fed rats
Shu, H., Isenberg, K., Cormier, R. J., Benz, A. M., & Zorumski, C. F. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.071 · Cited by 65
Gerhart, D. Z., Leino, R. L., Borson, N. D., Taylor, W. E., Gronlund, K. M., McCall, A. L., & Drewes, L. R. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00544-f · Cited by 63
GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus
Reagan, L. P., Rosell, D. R., Alves, S. E., Hoskin, E. K., McCall, A. L., Charron, M. J., & McEwen, B. S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02308-9 · Cited by 61
McClory, H., Williams, D., Sapp, E., Gatune, L. W., Wang, P., DiFiglia, M., & Li, X. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0178-7 · Cited by 60
The Na+/glucose cotransporters: from genes to therapy
Silva, R. S., Mori, R. C. T., David-Silva, A., Okamoto, M. M., Freitas, H. S., & Machado, U. F. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500115 · Cited by 59
Hoyer, S., Nitsch, R. M., & Oesterreich, K. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90691-2 · Cited by 58
Mechanisms linking brain insulin resistance to Alzheimer's disease
Matioli, M. N. P. D. S., & Nitríni, R. (2015) · Dementia & Neuropsychologia · doi:10.1590/1980-57642015dn92000003 · Cited by 58
Glucose, stress, and hippocampal neuronal vulnerability
Reagan, L. P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51009-6 · Cited by 56
Glucose transport in primary cultured neurons
Heidenreich, K. A., Gilmore, P. R., & Garvey, W. T. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220405 · Cited by 55
Blood-Brain Barrier Transport of Glucose, Free Fatty Acids, and Ketone Bodies
Pardridge, W. M. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5931-9_5 · Cited by 53
Genes required for fructose metabolism are expressed in Purkinje cells in the cerebellum
Funari, V. A., Herrera, V. L. M., Freeman, D. K., & Tolan, D. R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.09.019 · Cited by 51
Low Glucose Enhances Na + /Glucose Transport in Bovine Brain Artery Endothelial Cells
Nishizaki, T., & Matsuoka, T. (1998) · Stroke · doi:10.1161/01.str.29.4.844 · Cited by 49
Vorbrodt, A. W., Dobrogowska, D. H., & Tarnawski, M. (2001) · Journal of Neurocytology · doi:10.1023/a:1016581801188 · Cited by 47
Changes in the glucose transporter of brain capillaries
Harik, S. I. (1992) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y92-252 · Cited by 47
Enhanced Neuronal Glucose Transporter Expression Reveals Metabolic Choice in a HD Drosophila Model
Besson, M. T., Alegría, K., Garrido-Gerter, P., Barros, L. F., & Liévens, J.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118765 · Cited by 46
Adult neural stem cells express glucose transporters GLUT1 and GLUT3 and regulate GLUT3 expression
Maurer, M. H., Geomor, H. K., Bürgers, H. F., Schelshorn, D. W., & Kuschinsky, W. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.012 · Cited by 46 · cited 1×
“The expression of GLUT3 mRNA as well as GLUT3 protein was also observed in adult neural stem cells cultured from the subventricular zone of rats [18].”
Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier
Ho, H. T. B., Dahlin, A., & Wang, J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00154 · Cited by 46
Stimulation of glycolytic key enzymes in cerebral cortex by insulin
Hoyer, S., Prem, L., Sorbi, S., & Amaducci, L. (1993) · NeuroReport · doi:10.1097/00001756-199307000-00039 · Cited by 41 · cited 1×
“Insulin receptors in human brain differ from the peripheral insulin receptors based on the amount of glycosylation [115].”
Translocable Glucose Transporters in the Brain
Alquier, T., Leloup, C., Lorsignol, A., & Pénicaud, L. (2006) · Diabetes · doi:10.2337/db06-s021 · Cited by 40 · cited 3×
“…mediator of central effects of insulin [24]; 2) it may provide additional glucose to motor neurons under conditions of higher energy demand [88]; 3) insulin may modulate, directly or indirectly, glucose uptake in discrete brain areas [89]; 4) GLUT4 may be involved in glucose-sensing mechanism [89].”
InfluentialGLUT2 Immunoreactivity in Gomori-positive Astrocytes of the Hypothalamus
Young, J. K., & McKenzie, J. C. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6375.2004 · Cited by 40 · cited 1×
“Dwyer et al. [58] suggest that GLUT2 is expressed only in astrocytes, while Manolescu et al. [71] suggest that GLUT2 is probably mainly expressed in astrocytes, and other researchers [72, 73] have found expression of this transporter in tanycytes.”
Amyloid β-Peptide Inhibits Neuronal Glucose Uptake by Preventing Exocytosis
Uemura, E., & Greenlee, H. W. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7719 · Cited by 37
Lace, G. L., Wharton, S. B., & Ince, P. G. (2007) · Clinical Neuropathology · doi:10.5414/npp26043 · Cited by 37 · cited 1×
“According to Lace et al. [127], abnormally phosphorylated tau proteins bind to each other and tie themselves into “knots” that are known as intracellular neurofib-rillary tangles (NFTs) in cell bodies and proximal dendrites.”
Hassel, B., Elsais, A., Frøland, A., Taubøll, E., Gjerstad, L., Quan, Y., Dingledine, R., & Rise, F. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13079 · Cited by 36
Blood‐Brain Barrier Abnormalities in Alzheimer's Diseasea
HARIK, S. I., & KALARIA, R. N. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00189.x · Cited by 35
Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease
Simpson, I. A., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410360522 · Cited by 33
Cardiovascular Dementia - A Different Perspective
Kumari, U., & Heese, K. (2010) · The Open Biochemistry Journal · doi:10.2174/1874091x01004010029 · Cited by 32 · cited 3×
“Insulin is not synthesized in the brain by glial cells [74].”
InfluentialSimilar [DE]XXXL[LI] Motifs Differentially Target GLUT8 and GLUT12 in Chinese Hamster Ovary Cells
Flessner, L. B., & Moley, K. H. (2009) · Traffic · doi:10.1111/j.1600-0854.2008.00866.x · Cited by 31 · cited 1×
“TheproteinGLUT12 ispresentintheGolginetworkandintheplasma membrane[104].”
Augustin, R., & Mayoux, E. (2014) · InTech eBooks · doi:10.5772/58325 · Cited by 30 · cited 3×
“It is also expressed in synaptic dense-core vesicles of nerve terminals [21].”
InfluentialIntranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
Subramanian, S., & John, M. (2012) · PubMed · Cited by 25
Expression of the Glucose Transporter GLUT12 in Alzheimer's Disease Patients
Pujol‐Giménez, J., Martišová, E., Pérez‐Mediavilla, A., Lostao, M. P., & Ramírez, M. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132498 · Cited by 23
Lee, Y. J., Kim, J. E., Hwang, I. S., Kwak, M. H., Lee, J. H., Jung, Y. J., An, B. S., Kwon, H. S., Kim, B. C., KIM, S. J., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1404 · Cited by 22
Cerebral glucose transporter expression in HIV infection
Kovitz, C. A., & Morgello, S. (1997) · Acta Neuropathologica · doi:10.1007/s004010050685 · Cited by 13 · cited 1×
“Dis-turbancesofthisprocesswereobservedinpatients withAIDSdementiacomplex[15]andmyoclonic astaticepilepsy[16].”
Brain glucose transporter protein 2 and sporadic Alzheimer’s disease
Šalković‐Petrišić, M., & Riederer, P. F. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0030-y · Cited by 10
Welcome, M. O., & Pereverzev, V. A. (2014) · InTech eBooks · doi:10.5772/58241 · Cited by 4
Glucose transporter proteins in brain: Delivery of glucose to neurons and glia
Vannucci, S. J., Maher, F., & Simpson, I. A. (1997) · Glia · doi:10.1002/(sici)1098-1136(199709)21:1<2::aid-glia2>3.0.co;2-c · cited 1×
“TenGLUTproteinshavebeenidentifiedinthe centralnervoussystem[22,23](especiallyinthe brain)aswellasinperipheralnerves[17](Table1).”
Research works printed but not linked: 2
- Welcome, 2011, Long-term disorders of cognitive functions in sober people who episodically use alcohol, role of functional hypoglycemia and insufficiency of gluconeogenesis, Vestnik Smolensk Med Acad, 3, 2
- Welcome, 2013, State of cognitive functions of student-medics with different relationship to alcohol use, 5
Cited by
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
“Inefficient glucose utilization, impaired ATP production, and oxidative damage are closely correlated, and these deficiencies have profound consequences in AD.(387,388) For example, ATP deficiency causes the loss of the neuronal membrane potential since Na/K ATPase fails to maintain proper intracellular and extracellu…”
BackgroundVallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx073 · Cited by 226
“Hypometabolism of glucose and deficits in energy are observed in AD [107].”
BackgroundGlucose metabolic crosstalk and regulation in brain function and diseases
Zhang, S., Lachance, B. B., Mattson, M. P., & Jia, X. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102089 · Cited by 203
The solute carrier transporters and the brain: Physiological and pharmacological implications
Hu, C., Tao, L., Cao, X., & Chen, L. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.09.002 · Cited by 157
“SLCs function in energy metabolism he energy demands of the brain are very high and glucose s the obligatory energy substrate of the adult brain [57 ,58] . lucose is a polar, hydrophilic molecule that is transported argely via the glucose transporter SLC2A [59] .”
BackgroundInfluential
Metadata
- Authors
- Szablewski, L.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Szablewski, Leszek
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-12-20
- Volume
- 55
- Issue
- 4
- Pages
- 1307-1320
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2554650037
- Cited by
- 211
- References
- 161
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 25 · 2023: 20 · 2022: 30 · 2021: 32 · 2020: 35 · 2019: 19 · 2018: 6 · 2017: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- glucose transporters, Alzheimer's disease
- MeSH terms
- Acetylation, Alzheimer Disease, Animals, Brain, Gene Expression Regulation, Humans, Phosphorylation, tau Proteins, N-Acetylglucosaminyltransferases, Glucose Transport Proteins, Facilitative
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.